Panel Discussion: Highlighting Strategies to Streamline Regulatory Approval Across Regulatory Agencies

• Detailing the transition process between FDA, EMA and IIT clinical programs to streamline clinical development across borders
• Discussing strategies for incorporating early clinical readouts from international studies to enable faster decision making before US trial initiation
• Evaluating evolving US regulatory comfort with globally generated data to showcase how aligned global development strategies can accelerate innovation while maintaining regulatory rigor

Speakers:

Mark Exley

Chief Scientific Officer

LIfT BioSciences Ltd

Pei Wang

Senior Vice President, Clinical Development & CMC

Eureka Therapeutics